BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, July 6, 2026
Home » Topics » Briefs » Other news to note

Other news to note
Other news to note RSS Feed RSS

Other news to note for Jan. 5, 2026

Jan. 5, 2026
Biopharma happenings, including deals and partnerships, and other news in brief: Biogen, Genmab, Samsung Bioepis, Roche, Valneva.
Read More

Other news to note for Jan. 5, 2026

Jan. 5, 2026
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Accendra Health, Ceribell, Conformal Medical, Gore, Lantheus, Orasure Technologies, Shine Technologies.
Read More

Other news to note for Jan. 2, 2026

Jan. 2, 2026
Biopharma happenings, including deals and partnerships, and other news in brief: Arbormed, Bioatla, Gatc, Emmaus, Hyloris, Neoimmunetech, Novo Nordisk.
Read More

Other news to note for Jan. 2, 2026

Jan. 2, 2026
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Lantheus, Modular Medical, Owens & Minor, Shine Technologies.
Read More

Other news to note for Dec. 31, 2025

Dec. 31, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Koru Medical Systems.
Read More

Other news to note for Dec. 31, 2025

Dec. 31, 2025
Biopharma happenings, including deals and partnerships, and other news in brief: Hyloris, Nido, Rosemont, Takeda, Xoma.
Read More

Other news to note for Dec. 30, 2025

Dec. 30, 2025
Biopharma happenings, including deals and partnerships, and other news in brief: Adlai Nortye, Aosaikang, Halda, Harbour Biomed, J&J, Lannacheng.
Read More

Other news to note for Dec. 30, 2025

Dec. 30, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Capsovision, Vicarious Surgical.
Read More

Other news to note for Dec. 30, 2025

Dec. 30, 2025
Biopharma happenings in Asia-Pacific including deals and partnerships, grants, preclinical data and other news in brief: Bioeq, JCR Pharmaceuticals, Ipsen, Italfarmaco, Simcere Zaiming, Zydus.
Read More

Other news to note for Dec. 29, 2025

Dec. 29, 2025
Biopharma happenings, including deals and partnerships, and other news in brief: Gilead, Italfarmaco, JCR, Repare.
Read More
Previous 1 2 … 14 15 16 17 18 19 20 21 22 … 1401 1402 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 6, 2026.
  • CINP 2026: Prenatal and adolescent stress shape brain vulnerability

    BioWorld Science
    Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
  • Ontrack Therapeutics divulges compounds for neurodegenerative diseases

    BioWorld Science
    Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
  • Modius Spero wearable neuromodulation device

    Neurovalens granted FDA approval for PTSD therapy for US veterans

    BioWorld
    Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
  • IPO puzzle pieces

    Neuracle eyes Shanghai IPO as global BCI funding surges

    BioWorld
    Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing